Skip to content
DAT Supply Log in
Botanicals · Gummies

Banaba leaf extract

Banaba leaf extract is a botanical ingredient derived from the leaves of Lagerstroemia speciosa, a tree native to Southeast Asia. It is used in private-label gummy and sachet formulations for metabolic wellness positioning. As a botanical on the EFSA on-hold list, it carries no authorised EU health claims under Reg. (EU) 432/2012, so brand positioning relies on traditional use context or co-formulated nutrients with authorised claims.

  • blood-sugar-management
  • metabolic-support
  • botanical-wellness
Build a formula with this ingredient
Banaba leaf extract

At a glance

Definition
Banaba leaf extract is a botanical ingredient derived from the leaves of Lagerstroemia speciosa, a tree native to Southeast Asia. It is used in private-label gummy and sachet formulations for metabolic wellness positioning. As a botanical on the EFSA on-hold list, it carries no authorised EU health claims under Reg. (EU) 432/2012, so brand positioning relies on traditional use context or co-formulated nutrients with authorised claims.
Authorised wording (summary)
2 authorised statements — see "US structure-function statements" below.
Common positionings
  • Blood sugar management
  • Metabolic wellness
  • Healthy carbohydrate metabolism
  • Post-meal glucose support
  • Herbal metabolic aid
Format suitability
Reviewed for gummies and sachets — confirmed per project.
Format & category fit

Where this ingredient fits in the DAT Supply catalogue

Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.

Positioning

What it is

Banaba leaf extract is a botanical ingredient sourced from the leaves of Lagerstroemia speciosa, a tree traditionally used in Southeast Asian herbal medicine. The extract is standardised to corosolic acid, a triterpenoid compound considered the primary active marker. In private-label manufacturing, Banaba leaf extract is positioned within metabolic wellness and healthy carbohydrate metabolism ranges, often alongside other botanical or nutrient co-actives.

Brands choose Banaba leaf extract for its established presence in the botanical wellness category and its compatibility with gummy and sachet formats. Because it is a botanical on the EFSA on-hold list, no authorised health claims are available under applicable claims framework. This means pack copy must be carefully managed, relying on traditional use language or co-formulated nutrients with authorised claims to support the product's positioning.

Origin and history

Lagerstroemia speciosa, commonly known as banaba or crepe myrtle, is a flowering tree native to tropical regions of Southeast Asia, including the Philippines, India, and Malaysia. The leaves have been used in traditional herbal systems for generations, primarily in decoctions and teas, as part of dietary and wellness practices. The plant's common name "banaba" originates from the Tagalog language in the Philippines.

Industrial production of Banaba leaf extract involves harvesting the leaves, drying them, and extracting the active compounds using food-grade solvents such as ethanol or water. The extract is then standardised to a specified corosolic acid content, typically around 1%, to ensure batch-to-batch consistency. This standardisation is critical for commercial use, as it allows formulators to dose the ingredient reliably across production runs.

Scientific overview

The primary active compound in Banaba leaf extract is corosolic acid, a pentacyclic triterpenoid. Corosolic acid is understood to influence cellular glucose uptake mechanisms, though the exact pathways are still under investigation. Other constituents include ellagitannins such as lagerstroemin and flosin B, which may contribute to the extract's overall bioactivity. The ingredient is typically standardised to corosolic acid content for quality control purposes.

Bioavailability of corosolic acid from Banaba leaf extract is considered moderate, with absorption influenced by the presence of other phytochemicals in the extract matrix. The powdered extract is generally soluble in gummy formulations, though the herbal character may require flavour masking depending on dosage. Heat stability is good, making Banaba leaf extract suitable for the gummy manufacturing process, which involves heating and setting stages.

From a manufacturing perspective, the key watchpoints are extract standardisation, particle size, and solubility in the chosen format. Cost per milligram is moderate compared to synthetic actives but competitive within the botanical category. DAT reviews these parameters per project to ensure the ingredient performs as expected in the final product.

Why brands use Banaba leaf extract

Banaba leaf extract is one of the more familiar botanical ingredients in the metabolic wellness category across EU and US markets. Brands use it to create gummy products positioned around healthy carbohydrate metabolism and post-meal wellness. Because it is a botanical with traditional use history, it appeals to consumers seeking plant-based, natural-origin ingredients in their daily wellness routines. The ingredient is often combined with Chromium, which carries an authorised EU claim for normal macronutrient metabolism, or with other botanicals like Cinnamon extract to build a comprehensive metabolic wellness formula.

From a formulation and manufacturing perspective, Banaba leaf extract performs well in gummy formats. It is heat-stable, soluble in the gummy matrix, and does not present significant taste challenges at typical dosages of 24–100 mg per serving. The herbal bitterness can be managed with complementary fruit flavours such as berry or citrus. Sachet formats are also viable, particularly for powdered blends where the extract can be combined with other powdered nutrients. DAT confirms the specific formulation parameters, including particle size and solubility, during the development phase.

Pack copy for Banaba leaf extract requires careful claim discipline. Because it is a botanical on the EFSA on-hold list, no authorised health claims are available under applicable claims framework. Brands should avoid any language that implies blood sugar reduction, glucose control, or diabetes management in EU consumer-facing copy. Positioning should focus on traditional use, botanical wellness, or co-formulated nutrient claims. DAT reviews all claim wording per project and market before final label approval to ensure compliance.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Formulation notes

Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit
Good
Heat stable
Yes
Soluble in matrix
Yes
Cost tier
Medium

Forms available

  • Standardised extract (typically 1% corosolic acid), powdered extract, liquid extract

Dosage reference

Brand positioning range typically 24–100 mg per serving. No reference-intake target reviewed per market established for Banaba leaf extract. Dosage confirmed per project based on extract standardisation and target market.

Taste & sensory

Mildly bitter, herbal character. Masking may be required in gummy formats depending on dosage and co-formulated flavours.

Manufacturing notes

Standardised to corosolic acid content for batch consistency. Particle size and solubility confirmed per project. DAT reviews formulation parameters during development.

Format considerations

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Gummies

  • Taste masking and aroma load against the cooked-base flavour — confirmed per project.
  • Heat exposure during cooking; coated or encapsulated forms may be required — confirmed per project.
  • Matrix choice (pectin vs gelatin) and its effect on ingredient stability — confirmed per project.
  • Per-gummy dose and serving count needed to hit the label claim — confirmed per project.

Develop in gummies →

Sachets

  • Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
  • Barrier requirements (oxygen, moisture) for the active — confirmed per project.
  • Reconstitution behaviour when the sachet is dosed into water — confirmed per project.

US structure-function statements

  • Supports healthy carbohydrate metabolismStructure-function (DSHEA)
  • Helps maintain healthy blood sugar levels already within the normal rangeStructure-function (DSHEA)

Structure-function statements must appear with the FDA disclaimer in the same field of vision on the label. % Daily Value (DV) based on FDA 21 CFR 101.9.

Wording to avoid on pack copy

  • No disease claims — cannot claim to treat, cure, or prevent diabetes or any other disease.
  • Structure-function claims must be accompanied by the FDA disclaimer: 'These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.'
  • No certification promises on pack until confirmed per project and batch documentation.
  • No guaranteed shelf-life on pack until confirmed with stability data.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Structure-function claims are permitted under DSHEA (21 USC §343(r)(6)). No Daily Value (DV) has been established for Banaba leaf extract under FDA 21 CFR 101.9.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Studies & evidence

External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.

  1. Stohs, S.J., Miller, H., Kaats, G.R.·Phytotherapy Research·2012

  2. Klein, G., Kim, J., Himmeldirk, K., Cao, Y., Chen, X.·Evidence-Based Complementary and Alternative Medicine·2007

  3. Judy, W.V., Hari, S.P., Stogsdill, W.W., Judy, J.S., Naguib, Y.M., Passwater, R.·Journal of Ethnopharmacology·2003

  4. Miura, T., Itoh, Y., Kaneko, T., Ueda, N., Ishida, T., Fukushima, M., Matsuyama, F., Seino, Y.·Biological and Pharmaceutical Bulletin·2004

  5. EFSA NDA Panel·EFSA Journal·2011

Synergies & conflicts

Pairs well with

Often co-formulated with Chromium, Cinnamon extract, Berberine, or Alpha-lipoic acid for metabolic wellness positioning.

Care when combining with

No known significant conflicts with common gummy excipients or co-actives.

Similar ingredients

Ingredients that frequently sit alongside this one in private-label supplement briefs.

Adjacent reading

Pairings, resource guides and blog notes most often associated with Banaba leaf extract on DAT Supply briefs.

Common pairings

Ingredients that frequently co-formulate with Banaba leaf extract.

Project handoff

Develop a formula featuring Banaba leaf extract

Explore concepts already built around this ingredient, or talk to our team to scope a custom formulation.

Continue exploring

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Project documents, certificates and pricing are released through the project workspace in the DAT portal.

You will receive a short confirmation email. Project documents (specification, batch-specific COA, packaging documents) are released through the project workspace in the DAT portal once a brief is in place.